BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+21%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$2.84B
AUM Growth
+$2.84B
(+12%)
Cap. Flow
-$65.1M
Cap. Flow
% of AUM
-2.29%
Top 10 Holdings %
Top 10 Hldgs %
74.16%
Holding
31
New
1
Increased
10
Reduced
3
Closed
2
Top Buys
| 1 |
MacroGenics
MGNX
|
$28M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$16.1M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$15.1M |
| 4 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$14.5M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$9.91M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$120M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$18M |
| 3 |
CELG
Celgene Corp
CELG
|
$15.7M |
| 4 |
Puma Biotechnology
PBYI
|
$12.7M |
| 5 |
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
|
$5.88M |
Sector Composition
| 1 | Healthcare | 88.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Puma Biotechnology
PBYI
$254M
| $16.2M | 0.57% |
241,991
-190,000
| -44% | -$12.7M |
|
|
AVXS
27
DELISTED
AveXis, Inc. Common Stock
AVXS
| $14.5M | 0.51% |
+352,800
| New | +$14.5M |
|
|
ACHN
28
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $10.4M | 0.36% |
1,279,340
| – | – |
|
29
Cidara Therapeutics
CDTX
$1.66B
| $8.55M | 0.3% |
746,824
| – | – |
|
|
TBRA
30
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| – | – |
-468,000
| Closed | -$5.88M |
|
|
MDVN
31
DELISTED
MEDIVATION, INC.
MDVN
| – | – |
-1,991,112
| Closed | -$120M |
|